Under Armour: The EPS Beat Is an Illusion, the Guidance Cut Is the Truth

Under Armour (NYSE: UAA) reported first-quarter fiscal 2027 results today that looked like a beat on the surface and a warning shot underneath. The adjusted diluted EPS of $0.05 cleared the $0.023 consensus estimate, but revenue of $1.098 billion fell 3.2% year-over-year and missed the $1.215 billion the Street was modeling. The stock dropped approximately 3% to around $6.20 and has lost nearly 6% over the past five trading sessions, erasing much of the year-to-date gains that pushed it up 25% from its $4.13 52-week low.

The headline EPS beat is not the story. The story is that Under Armour's core business continues to shrink, the margin improvement is built on a one-time accounting reversal, and management just cut its full-year revenue outlook from a "slight decline" to a "mid-single-digit decline." The adjusted operating profit target is unchanged, but only because the company is slashing SG&A expenses while revenue falls. That is not a turnaround story — it is a cost-cutting exercise with a shrinking top line.

The Earnings Beat Is Built on Tariff Refunds, Not Operations

Gross margin expanded 590 basis points to 54.1% in the quarter, which looks impressive until you understand the composition. Approximately 150 basis points of the full-year gross margin expansion and $70 million of the expected operating income benefit come from refunds of prior-year IEEPA (International Emergency Economic Powers Act) tariff costs. IEEPA was a 2025 executive order that imposed tariffs on goods from certain countries, including key apparel manufacturing hubs. Under Armour expensed those tariff costs in fiscal 2026, and the refunds are now flowing back into the current period. This is a non-recurring recovery, not evidence of pricing power, cost discipline, or product mix improvement.

Strip out the tariff refunds, and the margin story is far less compelling. Gross margin would have expanded only modestly, offset by unfavorable foreign exchange, unfavorable regional and channel mix, and pricing headwinds. Operating income came in at $47 million ($52 million adjusted), which sounds positive for a company with negative trailing P/E ratios, but remember: the company is still burning cash. Trailing twelve-month free cash flow is negative $81 million. Operating cash flow is negative $14.8 million. The business is generating accounting profits while consuming cash.

Revenue Is Declining Everywhere That Matters

The geographic breakdown is the part that should concern investors most. North America — Under Armour's largest market and the engine of any apparel brand recovery — fell 9% to $610 million. This is not a quarterly blip. It is the continuation of a structural problem where Under Armour has lost ground to competitors on innovation, brand relevance, and wholesale relationships.

Asia-Pacific declined 7%, and while EMEA grew 12%, that region is a fraction of the North America base. The company also flagged approximately $35 million in full-year headwinds from the Middle East conflict, a geopolitical risk that is outside management's control but inside the guidance number.

By channel, both wholesale and direct-to-consumer are declining. Wholesale fell 2% to $638 million, signaling that retail partners are ordering less. Direct-to-consumer fell 6% to $437 million, with e-commerce specifically dropping 12%. E-commerce is the high-margin, scalable portion of DTC, and a double-digit decline there is a sign of weakening brand pull. Owned-and-operated stores are down 3%, suggesting foot traffic and conversion are not improving.

Product categories tell a similar story. Footwear, the higher-margin growth category for most athletic apparel companies, declined 8% to $245 million. Apparel, Under Armour's traditional strength, fell 2%. Accessories were down 4%. There is no category showing momentum.

The Guidance Cut Is the Real Signal

Management's updated full-year fiscal 2027 guidance is where the earnings beat becomes irrelevant:

• Revenue: Lowered from a "slight decline" to a mid-single-digit decline. North America was cut from a low-single-digit decline to a mid-single-digit decline. Asia-Pacific and EMEA were cut from low-single-digit growth to low-single-digit declines.
• GAAP EPS: Lowered from breakeven to a loss of $0.04 to a loss of $0.01 to $0.05.
• Adjusted EPS: Unchanged at $0.08 to $0.12.
• Operating income: Unchanged at $96 million to $116 million.
• SG&A: Now expected to decline at a high-single-digit rate (previously low-single-digit decline).

The adjusted EPS number sounds stable, but it is propped up by the tariff refund windfall and aggressive SG&A cuts. The GAAP EPS guidance is now a loss, which is worse than before the quarter. Management is essentially promising to maintain operating income on significantly lower revenue by cutting expenses, which is the definition of cutting your way to profitability rather than growing your way there.

For context, full-year fiscal 2026 revenue was $5.0 billion, down 4% year-over-year. If fiscal 2027 is a mid-single-digit decline, that puts it somewhere in the $4.4 to $4.7 billion range — a second consecutive year of revenue contraction.

Valuation: Cheap, But Is the Trap Priced In?

Under Armour trades at a market cap of $2.65 billion and an enterprise value of $2.93 billion on trailing revenue, yielding an EV/Sales multiple of approximately 0.59x. The price-to-sales ratio is 0.53x. The trailing P/E is negative because GAAP earnings are in the red. Forward P/E is effectively meaningless given the guidance. The company carries $3.0 billion in total debt against $309 million in cash, with a net debt position of $276 million.

Compared to Nike, which trades at a P/E of roughly 20x, an EV/EBITDA of 13.5x, a P/S of 1.34x, and pays a 3.9% dividend, Under Armour looks cheap on a multiple basis. But cheap is not the same as a buying opportunity when the business is declining, unprofitable, and cash-negative.

The analyst community reflects this caution. Under Armour carries a consensus "Reduce" rating across 20 analysts, with a price target range of $5.50 to $6.54 — essentially where the stock is trading now. The stock has fallen from its 52-week high of $8.15, but it has already retraced to the level where the Street sees fair value. There is no margin of safety.

Inventory: A Warning Sign in the Making

Inventory declined 3% to $1.1 billion year-over-year, which sounds like progress. But the more useful number is the sequential move: inventory rose approximately 21% from the prior quarter, which is typical for the back-to-school/summer build but concerning given the revenue decline. If demand continues to soften, that inventory becomes a markdown risk in fiscal Q2 and Q3. Markdowns eat gross margin, and gross margin is already being propped up by the non-recurring tariff refunds.

Cash sits at $396 million at quarter-end, with $200 million borrowed under the $1.1 billion revolving credit facility. The company just settled the remaining principal and interest on its Senior Notes due 2026, which removed one maturity wall but doesn't change the structural cash-burn problem.

What Would Change the Rating

Under Armour is not a stock I can buy here. The valuation has reset, but the business deterioration has not yet bottomed. Revenue is declining across geographies, channels, and categories. The margin story is a tariff accounting reversal. The company is unprofitable on a GAAP basis and burning free cash. The analyst consensus price target is already at the current stock price.

For me to consider a buy rating, I would need to see three things:

• Revenue stabilization: A quarter where North America revenue stops declining and the broader revenue decline narrows below the low single digits. The current guidance projects mid-single-digit declines through the year.
• Organic margin improvement: Gross margin expansion that does not rely on tariff refunds. The 150 basis points of refund-driven margin benefit is front-loaded and will not recur.
• Free cash flow positive: The company needs to demonstrate it can generate cash after capex. At -$81 million TTM, it cannot.

The next catalyst is the fiscal Q2 FY2027 earnings report, expected in early November 2026. That quarter will show whether the revenue decline is accelerating or stabilizing, whether the inventory build is converting to sales or building to a markdown risk, and whether the SG&A cuts are sustaining operating income or just masking the top-line problem.

Rating: Hold. The selloff from $8.15 to $6.20 looks steep on paper, but the business case has deteriorated enough that the stock is not cheap enough to ignore. Wait for revenue to stop falling, margins to improve organically, and free cash flow to turn positive before deploying capital here.